Home
>
National Drug Code (NDC)
>
Lithium
Lithium - 0054-3527-63 - (Lithium)
Drug Information of Lithium
| Product NDC: | 0054-3527 |
| Proprietary Name: | Lithium |
| Non Proprietary Name: | Lithium |
| Active Ingredient(s): | 8 meq/5mL & nbsp; Lithium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lithium
| Product NDC: | 0054-3527 |
| Labeler Name: | Roxane Laboratories, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018421 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19820429 |
Package Information of Lithium
| Package NDC: | 0054-3527-63 |
| Package Description: | 500 mL in 1 BOTTLE (0054-3527-63) |
NDC Information of Lithium
| NDC Code | 0054-3527-63 |
| Proprietary Name | Lithium |
| Package Description | 500 mL in 1 BOTTLE (0054-3527-63) |
| Product NDC | 0054-3527 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lithium |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 19820429 |
| Marketing Category Name | NDA |
| Labeler Name | Roxane Laboratories, Inc |
| Substance Name | LITHIUM CARBONATE |
| Strength Number | 8 |
| Strength Unit | meq/5mL |
| Pharmaceutical Classes | Mood Stabilizer [EPC] |
